Nu Skin Enterprises, Inc. (NUS) Given Average Recommendation of “Hold” by Brokerages
Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) have been given an average rating of “Hold” by the ten research firms that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $63.14.
A number of equities analysts recently commented on the stock. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Zacks Investment Research raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $78.00 price objective for the company in a research note on Saturday, December 30th.
In other news, President Ryan S. Napierski sold 11,667 shares of the company’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $63.84, for a total transaction of $744,821.28. Following the transaction, the president now directly owns 71,634 shares of the company’s stock, valued at $4,573,114.56. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Chairman Steven Lund sold 108,132 shares of the business’s stock in a transaction on Friday, December 22nd. The shares were sold at an average price of $68.81, for a total transaction of $7,440,562.92. Following the sale, the chairman now directly owns 4,769 shares in the company, valued at $328,154.89. The disclosure for this sale can be found here. Insiders sold 220,776 shares of company stock valued at $14,784,324 in the last three months. 5.20% of the stock is currently owned by insiders.
Nu Skin Enterprises (NUS) traded up $0.71 on Tuesday, reaching $68.67. The company had a trading volume of 334,400 shares, compared to its average volume of 313,744. The stock has a market capitalization of $3,615.48, a price-to-earnings ratio of 25.15, a P/E/G ratio of 2.24 and a beta of 1.56. Nu Skin Enterprises has a 12 month low of $47.10 and a 12 month high of $70.27. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.44.
Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Wednesday, November 1st. The company reported $0.76 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.76. Nu Skin Enterprises had a return on equity of 22.38% and a net margin of 6.97%. The business had revenue of $563.70 million during the quarter, compared to analyst estimates of $562.70 million. During the same quarter in the previous year, the business earned $0.98 earnings per share. The company’s revenue for the quarter was down 6.7% compared to the same quarter last year. analysts predict that Nu Skin Enterprises will post 3.23 earnings per share for the current year.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.